Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALB | P02768 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | OTC | P00480 | 1/20 | 0.31 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.31 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20797922 | 0.86 | — | — | |
| SCHEMBL20797791 | 0.86 | — | — | |
| SCHEMBL3732825 | 0.83 | ALOX15 (0.34) | ALOX15ALBNOS3NOS1NOS2 | |
| SCHEMBL1881323 | 0.83 | ALOX15 (0.34) | ALOX15ALBNOS3NOS1NOS2 | |
| SCHEMBL1419586 | 0.83 | ALOX15 (0.34) | ALOX15ALBNOS3NOS1NOS2 | |
| SCHEMBL2994242 | 0.83 | OTC (0.40) | ALOX15ALBNOS3NOS1NOS2 | |
| SCHEMBL2336282 | 0.83 | NOD1 (0.48) | ALBNOD1 | |
| SCHEMBL2336277 | 0.83 | NOD1 (0.48) | ALBNOD1 | |
| Hydrochloric Acid SCHEMBL28067882 | 0.82 | ALOX15 (0.33) | ALOX15ALBNOS3NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL28067883 | 0.82 | ALOX15 (0.33) | ALOX15ALBNOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102256936-B | Arginine derivative and cosmetic comprising same | NOF CORP | 2014-06-18 | — | — | CN | disclosed |
| EP-2377848-B1 | ARGININE DERIVATIVE AND COSMETIC COMPRISING SAME | NOF CORP (JP) | 2013-10-02 | — | — | EP | disclosed |
| US-8518994-B2 | Arginine derivative and cosmetic containing the same | NOF CORPORATION (JP) | 2013-08-27 | — | — | US | disclosed |
| EP-2377848-A1 | ARGININE DERIVATIVE AND COSMETIC COMPRISING SAME | NOF Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-20110245344-A1 | ARGININE DERIVATIVE AND COSMETIC CONTAINING THE SAME | NOF CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245344-A1 | ARGININE DERIVATIVE AND COSMETIC CONTAINING THE SAME | ARG1, ARG2, ARGLU1 | ALOX15 2865/4885ALB 3810/4885NOS3 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.